A Phase II, Open Label, Parallel Group, Multi-center Study to Compare the Pharmacokinetics of Tacrolimus in Adult Subjects Undergoing Primary Allograft Transplantation Receiving an Advagraf or Prograf Based Immunosuppressive Regimen, Including a Long-term Follow-up.
Phase of Trial: Phase II
Latest Information Update: 02 Dec 2014
At a glance
- Drugs Tacrolimus (Primary)
- Indications Heart transplant rejection; Kidney-pancreas transplant rejection; Lung transplant rejection; Pancreas transplant rejection
- Focus Pharmacokinetics
- Sponsors Astellas Pharma
- 22 Jan 2014 Status changed from active, no longer recruiting to completed as per ClinicalTrials.gov. record.
- 10 Jun 2013 Planned end date changed from 1 Jul 2016 to 1 Jul 2014 as reported by ClinicalTrials.gov.
- 10 Jun 2013 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.